ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Repke J. Snijder
Aart Brutel de la Rivière
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Snijder, R. J.
Right arrow Articles by van den Bosch, J. M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Snijder, R. J.
Right arrow Articles by van den Bosch, J. M. M.

Ann Thorac Surg 1998;65:212-216
© 1998 The Society of Thoracic Surgeons


Original Articles: General Thoracic

Survival in Resected Stage I Lung Cancer With Residual Tumor at the Bronchial Resection Margin

Repke J. Snijder, MD, Aart Brutel de la Rivière, MD, PhD, Hans J. J. Elbers, MD, Jules M. M. van den Bosch, MD

Department of Pulmonology, Sint Antonius Hospital, Nieuwegein, the Netherlands
Department of Thoracic Surgery, Sint Antonius Hospital, Nieuwegein, the Netherlands
Department of Pathology, Sint Antonius Hospital, Nieuwegein, the Netherlands

Accepted for publication July 23, 1997.

Dr Snijder, Department of Pulmonology, Sint Antonius Hospital, PO Box 2500, 3430 EM Nieuwegein, the Netherlands.

Background. Sometimes microscopic residual tumor is found at the bronchial resection margin despite an apparently complete resection of lung cancer. This may adversely affect the patient’s prognosis. Its impact on survival is unclear.

Methods. The records of 834 patients with resected stage I non–small cell lung cancer were studied. Patients with complete resection were assigned to the complete resection group (n = 802); patients with microscopic residual tumor at the bronchial resection margin that was accepted were assigned to the residual tumor group (n = 23). Residual tumor was classified as carcinoma in situ, mucosal residual disease, or peribronchial residual disease.

Results. The 5-year survival in the patients in the complete resection group was 54%; it was 58% in the residual tumor group with carcinoma in situ and 27.3% in the residual tumor group with invasive tumor (mucosal residual disease or peribronchial residual disease). The difference in survival between patients in the complete resection group and patients in the residual tumor group with invasive tumor was significant (p = 0.03).

Conclusions. The presence of mucosal or peribronchial residual disease, but not carcinoma in situ, at the bronchial resection margin in patients with stage I non–small cell lung cancer has an adverse effect on survival.




This article has been cited by other articles:


Home page
ICVTSHome page
E. Fernandez, P. L. de Castro, J. Astudillo, J. Fernandez-Llamazares, and and GCCB-S (Bronchogenic Carcinoma Cooperative Gro
Bronchial stump infiltration after lung cancer surgery. Retrospective study of a series of 2994 patients
Interactive CardioVascular and Thoracic Surgery, August 1, 2009; 9(2): 182 - 186.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. Collaud, M. Bongiovanni, J.-C. Pache, G. Fioretta, and J. H. Robert
Survival according to the site of bronchial microscopic residual disease after lung resection for non-small cell lung cancer.
J. Thorac. Cardiovasc. Surg., March 1, 2009; 137(3): 622 - 626.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. Wind, E. J. Smit, S. Senan, and J.-P. Eerenberg
Residual disease at the bronchial stump after curative resection for lung cancer
Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 29 - 34.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. G. Little, V. W. Rusch, J. A. Bonner, L. E. Gaspar, M. R. Green, W. R. Webb, and A. K. Stewart
Patterns of Surgical Care of Lung Cancer Patients
Ann. Thorac. Surg., December 1, 2005; 80(6): 2051 - 2056.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
S. Balasubramanian, J. Au, and J. Dunning
Should lobectomy patients with microscopic involvement of the bronchial resection margin undergo re-operation to improve their long-term survival?
Interactive CardioVascular and Thoracic Surgery, December 1, 2005; 4(6): 531 - 537.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
R. Rami-Porta, M. Mateu-Navarro, J. Freixinet, M. de la Torre, A. Jose Torres-Garcia, Y.-W. Pun, A. Canto Armengod, and on behalf of the Bronchogenic Carcinoma Cooperativ
Type of resection and prognosis in lung cancer. Experience of a multicentre study
Eur. J. Cardiothorac. Surg., October 1, 2005; 28(4): 622 - 628.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. Pasic, K. Grunberg, W. J. Mooi, M. A. Paul, P. E. Postmus, and T. G. Sutedja
The Natural History of Carcinoma In Situ Involving Bronchial Resection Margins
Chest, September 1, 2005; 128(3): 1736 - 1741.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
E. Ruffini, M. Bongiovanni, A. Cavallo, P.L. Filosso, R. Giobbe, M. Mancuso, M. Molinatti, and A. Oliaro
The significance of associated pre-invasive lesions in patients resected for primary lung neoplasms
Eur. J. Cardiothorac. Surg., July 1, 2004; 26(1): 165 - 172.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
L. L. Humphrey, S. Teutsch, and M. Johnson
Lung Cancer Screening with Sputum Cytologic Examination, Chest Radiography, and Computed Tomography: An Update for the U.S. Preventive Services Task Force
Ann Intern Med, May 4, 2004; 140(9): 740 - 753.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
C. Lequaglie, B. Conti, P.P. Brega Massone, and G. Giudice
Unsuspected residual disease at the resection margin after surgery for lung cancer: fate of patients after long-term follow-up
Eur. J. Cardiothorac. Surg., February 1, 2003; 23(2): 229 - 232.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Kara, E. Dikmen, D. Kilic, S. Dizbay Sak, D. Orhan, S. K. Kose, and S. Kavukcu
Prognostic implications of microscopic proximal bronchial extension in non-small cell lung cancer
Ann. Thorac. Surg., August 1, 2002; 74(2): 348 - 354.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
H.S. Hofmann, C. Taege, C. Lautenschlager, H. Neef, and R.E. Silber
Microscopic (R1) and macroscopic (R2) residual disease in patients with resected non-small cell lung cancer
Eur. J. Cardiothorac. Surg., April 1, 2002; 21(4): 606 - 610.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. Passlick, I. Sitar, W. Sienel, O. Thetter, and A. Morresi-Hauf
Significance of lymphangiosis carcinomatosa at the bronchial resection margin in patients with non-small cell lung cancer
Ann. Thorac. Surg., October 1, 2001; 72(4): 1160 - 1164.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Kara, S. Dizbay Sak, D. Orhan, and S. Kavukcu
Proximal bronchial extension with special reference to tumor localization in non-small cell lung cancer
Eur. J. Cardiothorac. Surg., August 1, 2001; 20(2): 350 - 355.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. D. Mitchell, D. J. Mathisen, C. D. Wright, J. C. Wain, D. M. Donahue, J. S. Allan, A. C. Moncure, and H. C. Grillo
Resection for bronchogenic carcinoma involving the carina: Long-term results and effect of nodal status on outcome
J. Thorac. Cardiovasc. Surg., March 1, 2001; 121(3): 465 - 471.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Fujimoto, G. Zaboura, S. Fechner, L. Hillejan, T. Schroder, A. Marra, T. Krbek, M. Hinterthaner, D. Greschuchna, and G. Stamatis
Completion pneumonectomy: Current indications, complications, and results
J. Thorac. Cardiovasc. Surg., March 1, 2001; 121(3): 484 - 490.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
G. Massard, C. Doddoli, B. Gasser, X. Ducrocq, R. Kessler, C. Schumacher, G.-M. Jung, and J.-M. Wihlm
Prognostic implications of a positive bronchial resection margin
Eur. J. Cardiothorac. Surg., May 1, 2000; 17(5): 557 - 565.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. J. Barnes
Bronchial Arterial Infusion for Lung Cancer
Chest, May 1, 2000; 117(5): 1525 - 1525.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
C. Ghiribelli, L. Voltolini, P. Paladini, L. Luzzi, M. Di Bisceglie, and G. Gotti
Treatment and survival after lung resection for non-small cell lung cancer in patients with microscopic residual disease at the bronchial stump
Eur. J. Cardiothorac. Surg., November 1, 1999; 16(5): 555 - 559.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
G. Massard, R. Kessler, B. Gasser, X. Ducrocq, S. Elia, S. Gouzou, and J.-M. Wihlm
Local control of disease and survival following bronchoplastic lobectomy for non-small cell lung cancer
Eur. J. Cardiothorac. Surg., September 1, 1999; 16(3): 276 - 282.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1998 by The Society of Thoracic Surgeons.